Parthenolide

Parthenolide

SCHEMBL1753337

C=C1C(=O)O[C@H]2C1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 13/20 1.00
ALDH1A1 P00352 4/20 1.00
LMNA P02545 3/20 1.00
TP53 P04637 3/20 1.00
CYP3A4 P08684 3/20 1.00
NFKB1 P19838 2/20 1.00
CYP1A2 P05177 2/20 1.00
STAT6 P42226 2/20 1.00
MAPT P10636 2/20 1.00
NLRP3 Q96P20 2/20 1.00
CASP1 P29466 1/20 1.00
PTGS2 P35354 1/20 1.00
NFKB2 Q00653 1/20 1.00
RELA Q04206 1/20 1.00
CYP2D6 P10635 1/20 1.00
TSHR P16473 1/20 1.00
MAPK1 P28482 1/20 1.00
THPO P40225 1/20 1.00
HTT P42858 1/20 1.00
HIF1A Q16665 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Parthenolide SCHEMBL29811034 1.00 PKM (1.00) PKMALDH1A1LMNATP53CYP3A4
Parthenolide SCHEMBL6479221 1.00 PKM (1.00) PKMALDH1A1LMNATP53CYP3A4
Parthenolide SCHEMBL20438846 1.00 PKM (1.00) PKMALDH1A1LMNATP53CYP3A4
Parthenolide SCHEMBL8219 1.00 PKM (1.00) PKMALDH1A1LMNATP53CYP3A4
Parthenolide SCHEMBL14418063 1.00 PKM (1.00) PKMALDH1A1LMNATP53CYP3A4
Parthenolide SCHEMBL14339765 1.00 PKM (1.00) PKMALDH1A1LMNATP53CYP3A4
Parthenolide SCHEMBL8220 1.00 PKM (1.00) PKMALDH1A1LMNATP53CYP3A4
Parthenolide SCHEMBL13367522 1.00 PKM (1.00) PKMALDH1A1LMNATP53CYP3A4
Parthenolide SCHEMBL21998728 1.00 PKM (1.00) PKMALDH1A1LMNATP53CYP3A4
Parthenolide SCHEMBL30383005 1.00 PKM (1.00) PKMALDH1A1LMNATP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9463170-B2 Chemosensory receptor ligand-based therapies ELCELYX THERAPEUTICS, INC. (US) 2016-10-11 US disclosed
US-9463170-B2 Chemosensory receptor ligand-based therapies ELCELYX THERAPEUTICS, INC. (US) 2016-10-11 US disclosed
US-20150265555-A1 Chemosensory Receptor Ligand-Based Therapies ANJI PHARMACEUTICALS INC. 2015-09-24 US disclosed
US-20150265555-A1 Chemosensory Receptor Ligand-Based Therapies ANJI PHARMACEUTICALS INC. 2015-09-24 US disclosed
US-8158372-B2 Agonists of a bitter taste receptor and uses thereof DEUTSCHES INSTITUT FÜR ERNÄHRUNGSFORSCHUNG POTSDAM-REHBRÜCKE (DE) 2012-04-17 US disclosed
US-8158372-B2 Agonists of a bitter taste receptor and uses thereof DEUTSCHES INSTITUT FÜR ERNÄHRUNGSFORSCHUNG POTSDAM-REHBRÜCKE (DE) 2012-04-17 US disclosed
US-20100056621-A1 AGONISTS OF A BITTER TASTE RECEPTOR AND USES THEREOF DEUTSCHES INSTITUT FUR ERNAHRUNGSFORSCHUNG (DE) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150265555-A1 Chemosensory Receptor Ligand-Based Therapies TAS1R2, TAS2R1, GPR119 PKM 2269/4885ALDH1A1 764/4885LMNA 3720/4885
US-20100056621-A1 AGONISTS OF A BITTER TASTE RECEPTOR AND USES THEREOF TAS2R4, TAS2R30, TAS2R40 PKM 3972/4885ALDH1A1 2399/4885LMNA 4825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.